Kerecis, a provider of tissue-regeneration materials, has been awarded a US patent for the use of fish skin in medical applications. The Kerecis material consists of sheets of intact, decellularized fish skin that have had all cells and ...
A new technology based on fish skin can be used to heal human skin wounds. This week, Kerecis Limited announced that it received FDA 510(k) clearance for a fish skin-based tissue regeneration technology. The technology is designed for the ...
Tags: Tissue Regeneration Technique, FDA
Iceland-based Kerecis has obtained 510(k) approval from the US Food and Drug Administration (FDA) to market its fish-skin, Omega3, tissue-regeneration technology for the treatment of chronic wounds in the US. The company will market the ...
Tags: Kerecis, PDA, Fish-Skin Technology, chronic wounds
The US Food and Drug Administration (FDA) has given 510(k) clearance for the marketing of Iceland-based Kerecis' proprietary fish-skin, omega-3, tissue-regeneration product for treating chronic wounds in the US. The product known as ...
Tags: Kerecis, Fish-Skin treatment, chronic wounds, FDA
Kerecis, a medical device company focused on the treatment of tissue damage with Omega3-based regenerative technologies, has announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 ...
Tags: Kerecis, Immunology Study
Kerecis has signed a collaboration agreement with Illinois-based Medline Industries, a manufacturer and distributor of healthcare products and services in the US. Kerecis is involved in developing and producing a tissue-regeneration ...